Agilon Health, INC Form 4 insider transactions
NYSE
Form 4: Agilon Health Director Jeffrey A. Schwaneke Reports Acquisition and Disposal of Common Stock
Director Jeffrey A. Schwaneke reports acquiring 32,119 shares of Agilon Health common stock and disposing of an unspecified amount on May 29, 2024.
NYSE
Director Sharad Mansukani reports acquiring 32,119 shares of Agilon Health common stock on May 29, 2024, and holding 1,274,033 shares following the transaction.
NYSE
Director Silvana Battaglia reports acquisition and disposal of Agilon Health (AGL) common stock and restricted stock units.
NYSE
Timothy Bensley, CFO of Agilon Health, reports the withholding of shares to cover income tax obligations related to the settlement of PSUs.
NYSE
Timothy Gertsch, Chief Accounting Officer of Agilon Health, reports acquiring and disposing of common stock and options, according to a recent SEC filing.
NYSE
Girish Venkatachaliah, Chief Technology Officer of Agilon Health, reports acquisition of restricted stock units and options, as well as shares withheld for tax obligations.
NYSE
Benjamin Shaker, Chief Markets Officer at Agilon Health, reports acquisition and disposal of company stock and stock options.
NYSE
Veeral Desai, Chief Strategy & Development Officer of Agilon Health, reports acquisition and disposal of company stock and options.
NYSE
CEO Steven Sell reports acquiring and disposing of agilon health, inc. shares, including restricted stock units and options, primarily for tax obligations and vesting purposes.
NYSE
Benjamin Kornitzer, Chief Medical & Quality Officer of Agilon Health, reports the vesting and settlement of performance-based restricted stock units (PSUs) and shares withheld for tax obligations.
NYSE
Girish Venkatachaliah, Chief Technology Officer of Agilon Health, reports the vesting and settlement of performance-based restricted stock units (PSUs) and shares withheld for tax obligations.
NYSE
Benjamin Shaker, Chief Markets Officer of Agilon Health, settled performance-based restricted stock units (PSUs) on March 14, 2024, resulting in the acquisition of 274,455 shares of common stock and the withholding of 95,266 shares for tax obligations.
NYSE
Veeral Desai, Chief Strategy & Development Officer at Agilon Health, reports the vesting and settlement of performance-based restricted stock units (PSUs) and shares withheld for tax obligations.
NYSE
Timothy Bensley, CFO of Agilon Health, reports the vesting and settlement of performance-based restricted stock units (PSUs) and shares withheld for tax obligations.